https://www.selleckchem.com/btk.html
There is a lack of well-conducted studies and therefore insufficient data for the efficacy and tolerability of bone medication in CD. In conclusion, both CD and menopause lead to bone loss. Identifying CD in postmenopausal women should lead to modification of osteoporosis management. Oral mucositis (OM) is a severe side effect in patients undergoing anticancer therapies, which negatively impacts on their quality of life often leading to either the interruption ofthe therapy. Photobiomodulation (PBM) is emerging as an effective strategy allowing a fa
Like
Comment
Share
